课题基金 / 基金详情

Structural and functional analysis of GCN2 for drug discovery

Structural and functional analysis of GCN2 for drug discovery
用于药物发现的 GCN2 结构和功能分析
批准号:
2757185
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2021
资助国家:
英国
项目状态:
未结题
起止时间:
2021 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Integrated Stress Response (ISR) is a growing research topic for drug discovery, as the pathway is vital for proper cellular function. The ISR senses environmental stresses by a set of four kinases which terminate global translation by phosphorylation of the eukaryotic initiation factor eIF2a. The response to amino acid starvation stress is facilitated by the general control non-derepressible 2 (GCN2) kinase - the are a number of clinical trials for cancer therapeutics targeting GCN2. Typically, levels of total and active/phosphorylated GCN2 are elevated in cancer cells. There is a lack of information regarding how GCN2 senses stress, especially with regards to structural data. This project aims to elucidate the inactive and active conformations of GCN2. The structures of each state/complex and conformation shifts will be observed by taking an integrative structural approach. Specifically, novel structures of each conformation will be obtained by Cryo- Electron Microscopy (cryoEM), as currently only highly truncated GCN2 structures obtained by X-ray Crystallography are available. In addition to 3D structures, dynamics data of GCN2 will be obtained using Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS). Where deuterium uptake levels are indicative of protein motion and can give peptide-level structural changes over time. The combination of cryoEM and HDX-MS provides structural validation, as well as visualization of protein motion. With understanding of protein structure, we can evaluate druggable sites on GCN2 by the use of nanobodies, and as such identify the sites for ligand design and drug development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
Got2基因对浆细胞样树突状细胞功能的调控及其在系统性红斑狼疮疾病中的作用研究
  • 批准号:
    82371801
  • 项目类别:
    面上项目
  • 资助金额:
    47.00万元
  • 批准年份:
    2023
  • 负责人:
    周海波
  • 依托单位:
利用CRISPR内源性激活Atoh1转录促进前庭毛细胞再生和功能重建
  • 批准号:
    82371145
  • 项目类别:
    面上项目
  • 资助金额:
    46.00万元
  • 批准年份:
    2023
  • 负责人:
    陶永
  • 依托单位:
SMC5-NSMCE2功能异常激活APSCs中p53/p16衰老通路导致脂肪萎缩和胰岛素抵抗的机制研究
  • 批准号:
    82371873
  • 项目类别:
    面上项目
  • 资助金额:
    50.00万元
  • 批准年份:
    2023
  • 负责人:
    乔洁
  • 依托单位:
基于再生运动神经路径优化Agrin作用促进损伤神经靶向投射的功能研究
  • 批准号:
    82371373
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    沃雁
  • 依托单位: